Navigation Links
New CEO Tom Zajac to Lead Wellcentive through Explosive Growth in Population Health Market
Date:9/12/2013

Atlanta, Georgia (PRWEB) September 12, 2013

Wellcentive announced today that veteran health IT executive and former Elsevier Chief Customer Officer Tom Zajac has joined the company as Chief Executive Officer and appointed board member, effective October 8, 2013.

Zajac brings with him more than 25 years’ experience in piloting health IT companies through initial public offerings, rapid growth and industry-leading customer satisfaction – critical leadership capabilities as customer adoption continues to accelerate for Wellcentive’s population health management solution.

Since it’s founding in 2005, Wellcentive has established a leadership position in healthcare outcomes management and data analytics with Wellcentive Advance™. The solution is used by over 7 thousand providers, covering 13 million patients throughout the United States, enabling healthcare organizations to proactively manage the widespread transition from fee-for-service to value-based reimbursement models such as Accountable Care (ACO), Patient Centered Medical Homes (PCMH), and Pay for Performance (P4P), and the accompanying shift of financial and outcome risk for patient populations from payers to providers.

“Tom is a highly experienced and growth focused leader, and brings significant industry and domain expertise, business acumen and commitment to delivering customer value,” said Allen Moseley, Wellcentive Investor and General Partner of Noro-Moseley Partners. “Tom is passionate about improving healthcare delivery through technology and has a clear vision for equipping Wellcentive to expand its leadership in population health management,” said Robert Crutchfield, Wellcentive Chairman of the Board and Partner at Harbert Management Corporation.

“This is a tremendous time of change for healthcare, and the industry’s ongoing transition to value-based medicine brings both new business models and new opportunities for payers and providers,” said Zajac. “Wellcentive offers a proven, best-of-breed solution that helps providers across the entire spectrum of care embrace and excel in that transition. We have the capabilities to significantly improve healthcare, and I’m excited to work with the Wellcentive management team to expand and deliver our product and services, and provide insight and innovation for our customers.”

Zajac most recently served as Chief Customer Officer of Elsevier, the world-leading provider of scientific, technical and medical information products and services, with responsibility for more than 3,000 healthcare customers. Tom joined Elsevier in 2011 as President and CEO of Elsevier|MEDai, a leading provider of predictive analytics and clinical solutions for payers and providers.

He was formerly President and CEO of CareScience, spending eight years building the company into one of the leading providers of quality improvement, regulatory reporting, HIE data exchange, and transformational services. Prior to CareScience, he spent eleven years building Transition Systems’ (TSI) success as the leader in healthcare decision support, with 1200 US and international provider and payer customers. TSI was acquired by Eclipsys, where Tom established and became President of the Business Solutions Division, providing advisory and transformation consulting to customers across its spectrum of products.

About Wellcentive
Since 2005, Wellcentive has delivered physician-facing, population health management and data analytics solutions that help clients improve clinical and financial outcomes. Wellcentive’s cloud-based, scalable, customizable Advance solution enables responsible population health management with industry-leading point of care tools, care gap analysis, automated patient outreach, outcomes reporting, predictive modeling and risk assessment, care management and coordination, and cost and utilization analysis. Wellcentive’s proprietary interfacing platform aggregates and normalizes clinical and administrative data from disparate sources, including EMRs, local and national labs, e-Rx, PMS, health systems, payers, HIEs and data warehouses. Wellcentive transforms this actionable data into meaningful information that enables preventive care, evidence-based chronic disease management, clinical integration, and participation in performance-based and risk-based reimbursement programs, including pay-for-performance, PCMH, PQRS and accountable care.

Thousands of providers and their organizations use Wellcentive solutions to deliver high-quality, cost-effective care for many millions of patients. Wellcentive’s leading-edge interfacing platform has approximately 2,000 live interfaces with a wide variety of local and national interfacing partners. Wellcentive’s clients include some of the most prestigious physician groups, physician organizations, health information exchanges, professional organizations and employer groups in the country. Wellcentive is a venture-backed organization with Noro-Moseley Partners and Harbert Management Corporation as the venture capital firms.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11115531.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Wellcentive Team Earns Prestigious PCMH Content Expert Certification
2. Terry Boch Joins Wellcentive as SVP, Sales and Marketing
3. Rockville, MD Dental Implants Now Have Improved Placement Through the Use of 3D Cone Beam Imaging with Dr. Steven N. Rice
4. New Season Sale, 20% Off on Silk Bedding Sets Throughout Online Store ElleSilk.com
5. LadybugSteamCleaners.com Extends Savings on Vapor Steam Cleaner Accessories Through November
6. J.C. DISI to drive positive change through "10-Day" Social Innovation Festival
7. The Health Briefs TV Show Airs Segment on Breakthrough Therapies
8. Molecular Imaging, Inc. Announces New Webinar: Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging
9. AED.com Offers 10% Off All Batteries and Pads Throughout September
10. Walgreens to Help Provide Up to 3 Million Life-Saving Vaccines for Children who Need Them Most Through Donation to United Nations Foundation’s Shot@Life Campaign
11. Heritage Healthcare Continues To Grow – Enters Florida With 7 New Rehab Partnerships Throughout The State.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: